EYÜPOĞLU, N. D.; ÇINAR, O. E.; AKSU, S.; BÜYÜKAŞIK, Y.; SAYINALP, N.; DEMIROĞLU, H.; GÖKER, H.; ÖZCEBE, O. İ.; HAZNEDAROĞLU, İ. C. Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate. Acta Medica, [S. l.], v. 53, n. 3, p. 277–283, 2022. DOI: 10.32552/2022.ActaMedica.745. Disponível em: https://actamedica.org/index.php/actamedica/article/view/745. Acesso em: 29 mar. 2024.